nodular bcc - HEALTHY
Healio: Superficial curettage, imiquimod cream 5% sees more failure at 5 years in nodular BCC Superficial curettage, imiquimod cream 5% sees more failure at 5 years in nodular BCC In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC). At 5 years ... Medicus Pharma (NASDAQ:MDCX) said on Wednesday its Phase 2 study of SkinJect (SKNJCT-003), a doxorubicin-containing microneedle array for nodular basal cell carcinoma (BCC), showed clinically ...
Context Explanation
Seeking Alpha: Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC) Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC) Healio: FDA clears AIV001 for testing for mixed BCC lesions in facial skin FDA clears AIV001 for testing for mixed BCC lesions in facial skin